6.5 -6.9
Testosterone IO-'M 6.5 -6.5
FSH 100 ng/ml 3.5 -2.5 Ye have r e c e n t l y reported t h a t , i n t h e t e s t l s , porclne lmmature S e r t o l i c e l l s cultured I n a s e r m -f r e e defined medium, r e l e a s e Somatomedln C / inurtunoreactive IGF 1 IlrSrnC) stlrnulated by FGF but n o t by GH (Ann. Endocrinol, 1985, &, 287) . In t h e p r e s e n t r e p o r t , we show t h a t SrnC/IGFI 1s a potent r e g u l a t o r of L q d i g c e l l d l f f e r e n t i a t l o n , The e f f e c t of SmC/IGF I on Le-ydig c e l l a c t i v i t y was studied by lncubatlrrg porclne Immature Leydig c e l l s wlth a b i o s y n t h e t l c 9mC. SmC/IGFI exerted a dose and time dependent stirnulatirig e f f e c t on Leydlg c e l l furictlon, wlth t h e ma.xlml response obtained a t 50 ng/ml a f t e r 48hrs treament. SmC/IGFl increased both LH/tlCG bindlng (x4-5), b a s a l ( x 4 ) and hCG-stimulated (~1 5 . 5 ) t e s t o s t e r o n e s e c r e t i o n . The s l i g h t e f f e c t s of SmC/IGFl (100ng/ml f o r 4Yhrs) on Leydlg c e l l nimber ( x l 3) and DNA s y n t h e s i s (~1 . 5 1 i n t h e comparison with t h e hlgh steroldogenic e f f e c t support the concept ttlat SmC/IGFI a c t s a 3 a c y t o d i f f e r e n c i a t i v e f a c t o r r a t h e r ttfin a growth f a c t o r . The steroldogenic a c t l o n of SuC/IGFl was not suppressed by cytosine arabinoside C. a DNA s-ynthesis i r h i b l t o r , supportlrig t h e concept of t h e c y t o d i f f e r e n c i a t l v e r o l e of t h l s p e p t l a e . I n conclusion, the production by S e r t o l i c e l l s of irSmC/If;FI associated wlth t h e s t l m u l a t l r g e f f e c t of SmC/IGFI on steroidogenesis, suggest t h a t t h i s peptide could be a n l n t r a t e s t l c u l a r regulator of Le-fdlg c e i i d l f i e r e n t l a t l o n Using affinity cross-linking we have shown the presence of Sm-C receptors (Cm-C-R) in cultured pig LC. The S$I-C-R were further characterized by competition binding (KD 1.10-M). When LC were cultured in a chemically defined medium without hormones, the number of Sm-C-R varied from 10000 to 15000 sites/cell. Treatment of LC with hCG induced a 2 to 3 fold increase in Sm-C-R. This effect was t+jne-(maximum effect after 48 h) and dose-dependent (ED50 = 10-M). Moreover LC treatment with Sm-C for 3 days induced an increase of hCG receptors (4-6 fold) and of hCG responsiveness (CAMP and testosterone production) (8-10 fold) with ED50 of about 2 ngldl. In addition, Sm-C stimulated LC DNA synthesis (ED50 = 10 nglml). These results show : 1) LC contain specific Sm-C-R which are positively regulated by hCG ; 2) Sm-C increased both hCC receptors number and hCG steroidogenic responsiveness of LC. Since Sertoli cells secrete Sm-C (see Chatelain et all our data strongly suggest that Sm-C might play a role in the paracrine regulation of LC. Therefore Sm-C could play a key role on the delayed puberty observed in children with isolated growth hormone deficiency. were determined in pregnant women and t h e i r infants. Longitudinal studies during pregnancy were performed in healthy women, women with GH deficiency (n=3) and women with diabetes o r gestational diabetes (n-44). IGF-I, IGF-I1 and SMBP were determined by radioimmunoassays using polyclonal antibodies.
The serum levels of IGF-I and SMBP, but not IGF-11, increased during pregnancy in both healthy women and women with diabetes. In GH deficient women the levels rose t o normal pregnant levels. The b i r t h weight percentile of the infants increased with the maternal IGF-I levels and decreased with the maternal SMBP levels. The r a t i o between maternal IGF-I and SMBP levels improved the correlation t o the b i r t h weight percentile. No correlation was found between the b i r t h weight and the isolated values of IGF-I, IGF-11, SMBP and C-peptide in cord blood. The IGF-I1 levels in cord blood from infants of diabetic womenwere 50% higher than those of nondiabetic women.
The correlation between maternal levels of the b i r t h weight of the infants indicates t h a t maternal IGF-I levels may play a role in the t r a n s f e r of nutrients t o the f e t u s . The elevated IGF-I1 levels in cord blood of infants of diabetic women suggest t h a t IGF-I1 could participate in the glucose homeostasis of the f e t u s . Hypopit. 12 51 6.0 500 65 9.8 0.6 In foetuses, IGF I levels were similar to those in cases of total GH deficiency. IGF I1 levels were on average 6.5 times those of IGF I. No correlation was seen between IGF levels and growth parameters estimated by ultrasounds. Western blot analysis of IGF-BPS showed that foetal serum contained smaller quantities than normal adult serum of 42 and 39 K MW forms (which in the adult appear chiefly in t h e -150 K [IGF-BPI complex) and large quantities of the 34 and 30 K forms, which have a selective a f f i n i t y for IGF I1 and are minor forms in adults. Such a pattern occurs in GH deficiency. Conclusion : The profile of IGFs and IGF-BPS in foetal serum i s similar to that seen a f t e r birth when GH control i s absent. To investigate the regulation and physiological significance of SHBG in f e t a l l i f e , i t ' s distribution in maternal and f e t a l blood and in amniotic f l u i d was measured. In s p i t e of high circulating estrogens, the f e t a l SHBG-levels were 13.4-fold below the maternal blood-concentrations: 3.0 + 1.0 (SD) uglml (n = 62) versus 40.1 + 9.3 (SD) uglml (n = 64r. No significant difference was found regarding f e t a l sex in maternal and f e t a l blood: female 2.9 + 0.8 ug/ml (n = 29) and male 3.2 + 1.0 uglml (n = 33). In amniofic f l u i d the SHBG-concentration was 1.1 + 0.6 uglml in female and 0.9 _+ 0.5 in male pregnancies. This difference i s not significant. After the sharp f a l l of estrogens postnat a l l y the maternal SHBG-concentration declined by 50% during the f i r s t puerperal week. In contrast, t h e SHBG-levels increased by almost loo% during t h e f i r s t week in t h e newborns of both sexes (5.6 + 1.8 ug/ml). These findings suggest, t h a t f e t a l and maternal SHBG-1 eve1 s a r e independently regulated. Whi 1 e maternal SHBG i s strongly influenced by circulating estrogens, the regulation in fetuses and newborns seems t o be controlled by mechanisms othe r than induction and suppression by estrogens and androgens. I t may be speculated, t h a t the low SHBG-levels during f e t a l l i f e a r e related t o t h e increased biological steroid a c t i v i t y during t h i s period. In contrast t o other studies the measurement of SHBG in amniotic f l u i d did not prove t o help identify f e t a l sex. Supported by the DFG, Grant No. Si 32312-1
